40HU-010
iPSC分化的脑前叶γ-氨基丁酸神经元 （正常人）
Human Cortical GABAergic Neurons (iPSC-derived, Normal)
Cryopreserved, 1.0 million cells/vial · 2 种现有规格
产品与技术资料CELL CULTURE / PRODUCT
iPSC （二型糖尿病）
Human iPS Cell Line (Type 2 Diabetes)
- 产品代码
- 30HU-005
- 产品类别
- iPSC及分化细胞
- 现有规格
- Cryopreserved, 0.5-1.0 million cells/vial
原产品简介与规格资料
产品代码: 30HU-005
iPSC （二型糖尿病）
价格有浮动，详情咨询 (+86) 15750729215
产品规格
选择产品规格:
Cryopreserved, 0.5-1.0 million cells/vial
01 / PRODUCT INFORMATION
产品介绍
Product Description
Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells [1]. The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells.
iXCells Biotechnologies is proud to offer human iPS cell lines derived from the human dermal fibroblasts from patients with Type 2 Diabetes (T2D). The pertinent donor information is available upon request (info@amogene.com). These iPS cells are established from a single clone and expanded in feeder-free conditions. The Certificate of Analysis is provided for each cell lot purchased. The cells have been fully characterized for their self-renewal and pluripotency (Figure 1). All the cells provided by iXCells are negative for mycoplasma, bacteria, yeast, and fungi. HIV-1, hepatitis B and hepatitis C.
Normal human iPS cell lines are also available as separate products (Cat# 30HU-002). The currently available diseased specific iPS cell lines are derived from patients with Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Alzheimers's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS). More disease-specific iPS cell lines are under development. We also provide custom iPSC generation and iPSC differentiation services to meet your needs.
查看原资料图片：iPSC Parkinson's Disease ↗
Product Details
Figure 1. iXCells human iPS cells are characterized by immunostaining with Oct4, Nanog, SSEA4, TRA-1-60-R, TRA-1-81.
Product Details
| Tissue Origin | Human iPS Cells derived from dermal fibroblasts of Type 2 Diabetes patient |
| Package Size | ~0.5-1.0x106 cells/vial |
| Shipped | Cryopreserved |
| Storage | Liquid nitrogen |
| Growth Properties | Adherent |
| Media | Human iPSC Growth Medium (Cat# MD-0018) MEF Conditioned Media (Cat# MD-0015) Human iPSC Feeder-Free Growth Medium (Cat# MD-0019) Human iPSC Xeno-Free Growth Medium (Cat# MD00074) |
References
[1] Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011 May; 8(5):409-12.02 / PRODUCT INFORMATION
产品说明
Product Description
Induced Pluriopotent Stem Cells (iPSCs) are a type of pluripotent stem cells that can be derived directly from adult somatic cells [1]. The derived iPSCs can propagate indefinitely, as well as give rise to other cell types in the body. iPS cells, thus, hold great promise in the field of regenerative medicine by representing a single source of cells that could be used to replace those damaged/diseased cells.
iXCells Biotechnologies is proud to offer human iPS cell lines derived from the human dermal fibroblasts from patients with Type 2 Diabetes (T2D). The pertinent donor information is available upon request (info@amogene.com). These iPS cells are established from a single clone and expanded in feeder-free conditions. The Certificate of Analysis is provided for each cell lot purchased. The cells have been fully characterized for their self-renewal and pluripotency (Figure 1). All the cells provided by iXCells are negative for mycoplasma, bacteria, yeast, and fungi. HIV-1, hepatitis B and hepatitis C.
Normal human iPS cell lines are also available as separate products (Cat# 30HU-002). The currently available diseased specific iPS cell lines are derived from patients with Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Alzheimers's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS). More disease-specific iPS cell lines are under development. We also provide custom iPSC generation and iPSC differentiation services to meet your needs.
查看原资料图片：iPSC Parkinson's Disease ↗
Figure 1. iXCells human iPS cells are characterized by immunostaining with Oct4, Nanog, SSEA4, TRA-1-60-R, TRA-1-81.
Product Details
| Tissue Origin | Human iPS Cells derived from dermal fibroblasts of Type 2 Diabetes patient |
| Package Size | ~0.5-1.0x106 cells/vial |
| Shipped | Cryopreserved |
| Storage | Liquid nitrogen |
| Growth Properties | Adherent |
| Media | Human iPSC Growth Medium (Cat# MD-0018) MEF Conditioned Media (Cat# MD-0015) |
References
[1] Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011 May; 8(5):409-12.
SAME COLLECTION
继续浏览同类产品
30HU-008
iPSC（阿尔茨海默病）
Human iPS Cell Line (Alzheimer’s Disease)
Cryopreserved, 0.5-1.0 million cells/vial
产品与技术资料
30HU-004
iPSC （渐冻症病人）
Human iPS Cell Line (Amyotrophic Lateral Sclerosis)
Cryopreserved, 0.5-1.0 million cells/vial
产品与技术资料
30HU-002
人iPSC （健康人）
Human iPS Cell Line (Normal)
Cryopreserved, 0.5-1.0 million cells/vial
产品与技术资料BIOMO / 实验需求
